Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy: a novel cure for a rare degenerative corneal disease?

Fig. 1

Representative slit -lamp pictures showing the clinical progression of neurotrophic keratopathy after cenegermin treatment. A central, neurotrophic corneal lesion at baseline, B corneal lesion completely healed after 8 weeks of treatment, C corneal healing persisted at 12 months of follow up, and D after 24 months of follow up

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172